Interim Results

NMT Group PLC 22 August 2005 22 August 2005 NMT GROUP PLC Interim Results for the six months ended 30 June 2005 NMT Group PLC, the provider of drug delivery solutions to prevent needlestick injury, announces its interim results for the six months ended 30 June 2005. Key points • Prospective licensing contract for 2-G safety syringes in Far East - progressing to government-regulated bidding process for associated capital equipment. • Marketing trial for Safety Needle Unit with US pharmaceutical company underway • Company continuing to evaluate various strategic options • Loss before tax of £0.5m (June 2004: £1.2m) • Cash balances of £6.5m (December 2004 - £7.0m) in line with expectations. Commenting on the results, Tony Fletcher, Chairman, said: 'The Company is continuing its twin strategy of seeking to secure licensing agreements for its existing products and of evaluating strategic options for the business. The move to the bidding process, for associated capital equipment in the prospective Far East licensing contract for the 2-G safety syringes, represents a significant step forward in concluding pre-contractual requirements. Significant work is taking place in evaluating various strategic options for the business and we will revert to shareholders as soon as we have viable proposals to put forward.' Enquiries: NMT Group PLC Tony Fletcher - Chairman • Tel: 01506 445000 Gordon Beattie - Beattie Communications • Tel: 07768 588163 Trading Update In the trading update issued by the Company on 11 July 2005, I reported that the Company had not at that time signed a legally-binding contract with its prospective licensing partner in the Far East for the Company's 2nd Generation retractable safety syringes; and that the Company had not received any licence fee payments from that prospective licensing partner. Although no formal contract has been signed and no licence fee payments have been received to date, I can report that, following further negotiations, the Company received written confirmation on 18 August 2005 from the prospective licensing partner re-affirming its intention to enter into a legally-binding contract for the manufacture and distribution of the Company's 2nd Generation safety syringes in high volume; this being subject to a successful outcome in a formal, government-regulated bidding process in that party's jurisdiction (which is the next stage of the project process) and a resulting agreement between all parties on that outcome. The Board understands that the formal bidding process, once initiated, is likely to take approximately two months and addresses a major requirement in facilitating the signature of a formal contact. We believe that this development represents a significant step forward. In addition, I can report that talks are continuing with a major US-based pharmaceutical and medical devices company to license the manufacture and distribution of the Company's Safety Needle Unit. Market evaluation trials have commenced with the pharmaceutical company. Results An operating loss of £0.7m (2004:£0.7m) was incurred on continuing activities. This was offset by interest income of £0.2m, which resulted in an overall loss before tax of £0.5m (2004:£1.2m). Net cash outflow from operating activities for the half year was £0.7m and compared with £3.3m in the same period last year, which included a cash outflow of £2.8m relating to discontinued activities. Cash at 30 June 2005 was £6.5m (2004:£9.8m), reduced from £7.0m at 31 December 2004. Outlook The Company is continuing to evaluate various options with a view of seeking to identify the best way to maximise the value of the Company's assets for shareholders. Discussions are being held with a number of companies in the medical devices sector, which have expressed interest in the integration of the Company's technology and intellectual property into their own respective product portfolios. The Board will revert to shareholders as soon as it has viable proposals to be put forward. Tony Fletcher Chairman 22 August 2005 CONSOLIDATED PROFIT AND LOSS ACCOUNT For the six months ended 30 June 2005 6 months to 30 June 2005 6 months to 30 June 2004 12 months to 31 December 2004 Interim Continuing Continuing Discontinued Interim Continuing Discontinued Full year £'000 £'000 £'000 £'000 £'000 £'000 £'000 Turnover Distribution (153) (119) - (119) (252) - (252) costs Administration (526) (577) (148) (725) (1,177) (148) (1,325) expenses Exceptional - - (720) (720) - (696) (696) administration expenses Group operating (679) (696) (868) (1,564) (1,429) (844) (2,273) loss Exceptional items - - 73 73 - 73 73 Loss before (679) (696) (795) (1,491) (1,429) (771) (2,200) interest Interest 153 223 - 223 391 - 391 receivable Loss on ordinary (526) (473) (795) (1,268) (1,038) (771) (1,809) activities before taxation Taxation 28 38 - 38 71 - 71 Loss for the (498) (435) (795) (1,230) (967) (771) (1,738) financial period Loss per ordinary (5.7)p (5.0)p (9.1)p (14.1)p (11.1)p (8.9)p (20.0)p share basic and diluted Loss per share (5.7)p (5.0)p (2.0)p (7.0)p (11.1)p (2.0)p (13.1)p before exceptional items NOTES 1. Basis of preparation The financial information in this report does not comprise statutory accounts for the purposes of Section 240 of the Companies Act 1985. The interim accounts are unaudited but have been formally reviewed by the auditors and their report is set out on page 5. These interims have been prepared on the basis of accounting policies consistent with those set out in the Company's full accounts for the year ended 31 December 2004. The accounts for the year ended 31 December 2004 presented in this report are an abridged version of the full accounts which carried an unqualified auditors' report, did not contain a statement under either Section 237(2) or Section 237(3) of the Companies Act 1985 and have been filed with the Registrar of Companies. There is no difference between the loss on ordinary activities before taxation and the retained loss for the period stated above and their historical cost equivalents. The company has no recognised gains or losses other than its losses for the respective financial periods. 2. Taxation As a result of losses brought forward there is anticipated to be no tax charge in the current year. The tax credit reflects a research and development tax credit for the period. 3. Loss per share The calculation of loss per share is based on the loss for the period attributable to ordinary shareholders and on the average number of ordinary shares in issue during the period, which totalled 8,711,317 shares (2004 interim - 8,711,317: full year - 8,711,317). As a loss has been incurred during the six months ended 30 June 2005, there is no dilutive effect of unexercised share options. CONSOLIDATED BALANCE SHEET As at 30 June 2005 Interim Interim Full year 30 June 30 June 31 December 2005 2004 2004 £'000 £'000 £'000 Fixed assets Tangible assets 261 338 301 Current assets Debtors 179 638 232 Cash at bank and in hand 6,514 9,753 7,005 6,693 10,391 7,237 Creditors: amounts falling due within one (193) (452) (279) year Net current assets 6,500 9,939 6,958 Total assets less current liabilities 6,761 10,277 7,259 Provisions for liabilities and charges (2,510) - Net assets 6,761 7,767 7,259 Capital and reserves Called up share capital 37,187 37,187 37,187 Share premium account 38,639 38,639 38,639 Profit and loss account (69,065) (68,059) (68,567) Total shareholders' equity funds 6,761 7,767 7,259 CONSOLIDATED CASH FLOW For the six months ended 30 June 2005 Interim Interim Full year 2005 2004 2004 £'000 £'000 £'000 Net cash (outflow)/inflow - continuing operations (671) (537) 249 Net cash outflow - discontinued business - (2,751) (6,237) Net cash outflow from operating activities (671) (3,288) (5,988) Returns on investments & servicing of finance Interest received (net) 181 231 418 Taxation - 195 195 Capital expenditure (1) - (5) Cash outflow before management of liquid resources and financing (491) (2,862) (5,380) Management of liquid resources 439 2,251 5,003 Cash outflow before financing (52) (611) (377) Financing Finance lease - repayment of principal - (227) (457) Net cash outflow from financing - (227) (457) Decrease in cash in the period (52) (838) (834) Reconciliation of net cashflow to movement in net funds Decrease in cash in the period (52) (838) (834) Cashflow from finance leases-repayments of principle - 227 457 Cash outflow from decrease in liquid resources (439) (2,251) (5,003) Decrease in net funds in period (491) (2,862) (5,380) Net funds at beginning of period 7,005 12,385 12,385 Net funds at end of period 6,514 9,523 7,005 Net funds are analysed as: Cash 6,514 9,753 7,005 Finance lease liability - (230) - Net funds at end of period 6,514 9,523 7,005 RECONCILIATION OF SHAREHOLDERS' FUNDS For the six months ended 30 June 2005 Interim Interim Full year 2005 2004 2004 £'000 £'000 £'000 Total movements during the period (498) (1,230) (1,738) Shareholders' funds at start of period 7,259 8,997 8,997 Total shareholders' funds at end of period 6,761 7,767 7,259 INDEPENDENT REVIEW REPORT Introduction We have been instructed by the company to review the financial information for the six months ended 30 June 2005 which comprises the Group Profit and Loss Account, the Reconciliation of Movements in Shareholders' Funds, the Group Cash Flow Statement and the related notes. We have read the other information contained in the interim report and considered whether it contains any apparent misstatements or material inconsistencies with the financial information. Directors' responsibilities The interim report, including the financial information contained therein, is the responsibility of, and has been approved by the directors. The directors are responsible for preparing the interim report in accordance with the Listing Rules of the Financial Services Authority which require that the accounting policies and presentation applied to the interim figures should be consistent with those applied in preparing the preceding annual accounts except where any changes, and the reasons for them, are disclosed. Review work performed We conducted our review in accordance with guidance contained in Bulletin 1999/4 issued by the Auditing Practices Board for use in the United Kingdom. A review consists principally of making enquiries of management and applying analytical procedures to the financial information and underlying financial data and, based thereon, assessing whether the disclosed accounting policies have been applied. A review excludes audit procedures such as tests of controls and verification of assets, liabilities and transactions. It is substantially less in scope than an audit performed in accordance with United Kingdom Auditing Standards and therefore provides a lower level of assurance than an audit. Accordingly we do not express an audit opinion on the financial information. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Listing Rules of the Financial Services Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. Review conclusion On the basis of our review we are not aware of any material modifications that should be made to the financial information as presented for the six months ended 30 June 2005. PricewaterhouseCoopers LLP Chartered Accountants and Registered Auditors Glasgow 19 August 2005 Notes: (a) The maintenance and integrity of the NMT Group plc web site is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the interim report since it was initially presented on the web site. (b) Legislation in the United Kingdom governing the preparation and dissemination of financial information may differ from legislation in other jurisdictions. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings